Mr. Rif kin said that would be suitable. 
Mr. Mitchell suggested that the matter be discussed over a break, 
and perhaps some language could be developed. He then adjourned 
the committee for its morning break. 
Mr. Mitchell reconvened the committee at 10:47 a. m. He said that 
in all his years on the committee, he did not believe this 
particular issue and language had ever come up for discussion. 
Since it was very complex, he would welcome suggestions on how 
best to continue. 
Dr. Pirone said he had an extensive discussion with members of 
the committee at the break. The consensus was that it could not 
be resolved at today’s meeting. Perhaps a position paper could 
be assembled, put out for comment, and placed on the agenda for 
the next meeting of the RAC. 
Dr. Walters moved that a working group be set up to study Section 
I-C of the NIH Guidelines and to report back at the next meeting 
of the RAC. The motion was seconded by Dr. Pirone. 
Dr. Johnson asked that in light of the ruling by NIH counsel 
whether the counsel would be a part of the working group. 
Dr. Joklik supported the setting up of the working group. He 
restated his views that U.S. researchers not use another country 
as a '’ dumping ground" against that country's wish. The other 
country should have some voice in approving agents for testing 
within their borders. He believed the language currently stated 
in Section I-C is sufficient to ensure applicability of the NIH 
Guidelines abroad when NIH money is involved in the research. 
Dr. Korwek said he was in favor of setting up the working group. 
The Food and Drug Administration (FDA), and the U.S. Department 
of Agriculture (USDA) regulations, and other Federal laws need to 
be looked at in terms of the extraterritorial application of the 
NIH Guidelines. 
Mr. Mitchell asked for further discussion. Upon hearing none, he 
put the motion to have the Chair appoint a working group to study 
Section I-C of the NIH Guidelines and to report back to the next 
meeting of the RAC to a vote. The result of the voting was 17 in 
favor, 2 opposed, and no abstentions. Mr. Mitchell stated he 
would announce the committee members at the start of the 
afternoon session. 
Mr. Rif kin asked for a point of clarification as to what would 
occur should there be a similar incident between today’s meeting 
and the next meeting of the RAC, and he asked that some 
appropriate interim policy be established. 
[56] 
Recombinant DNA Research, Volume 13 
